United States · 
Who invested in Ziarco?
Ziarco's investors include New Enterprise Associates, Innovate UK, Pfizer, Lundbeckfond Ventures and Amgen Ventures, and 1 more on record.
20132014
$7.6MSeries A$33MSeries BUnited States · Series B startup
Who invested in Ziarco
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$41Mraised across 2 rounds since 2012, from 2 sources
$7.6MSeries A$33MSeries B
- Latest round
- Series B, $33MNov 2014
- Step-upi
- 4.3×
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $7.6M Oct 2012
- Biggest round
- $33M Series B · Nov 2014
- Between rounds
- 2 years from the last two
The rounds
- Nov 2014Series B$33M6 new
From a historical funding record
- Oct 2012Series A$7.6M
No investor was named in the report.
Reported by sec.govSEC filing: $7.6M sold, first sale Oct 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Lundbeckfond VenturesVC firm1round
Amgen VenturesGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ziarco
How much has Ziarco raised?
Ziarco has raised $41M across 2 rounds since 2012.
When did Ziarco last raise?
Ziarco's most recent round was a Series B of $33M in Nov 2014.
What was Ziarco's biggest round?
Its most recent round, $33M in Nov 2014, is also its largest on record.
Who backed Ziarco first?
Ziarco's first round on record, in Nov 2014, was backed by New Enterprise Associates, Innovate UK and Pfizer and 3 others.
What stage is Ziarco at?
Ziarco's latest named round is a Series B, in Nov 2014.
Where is Ziarco based?
Ziarco is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.